China
Parkway MediCentre Xintiandi in Shanghai
Parkway MediCentre Xintiandi in Shanghai
It is connected to Parkway Shanghai Hospital and the Parkway 百汇医疗 clinic network.
4 days ago
China's licensing boom reshapes global pharma power
Record-breaking BD deals reflect Beijing's innovative assets are gaining massive international recognition.
5 days ago
Why China's pharma market is now a consumer game
Stakeholders must understand this moment, as it signifies a fundamental shift in the industry.
5 days ago
China’s pharma growth shifts from drugs to high-tech manufacturing
However, there is still a lot of pressure in pharmaceutical manufacturing.
5 days ago
Perennial Holdings, Ruijin Hospital to build international medical platform
The partnership also includes a talent training and exchange programme.
Medical devices supply chains at risk as China tightens rare earth exports
Sectors most exposed include MRI and X-ray device production.
Melco launches integrated resort hospital at Studio City Macau
The new iRad Hospital offers MRI and CT scanning.
China’s healthcare sector raises $10.6b through equity offerings
Strong activity is expected to continue in the second half.
Perennial to launch Shanghai’s first wholly foreign-owned tertiary hospital
The project is expected to carry a total investment cost of $69.4m (RMB500m).
China’s biopharma sector strikes $30b in oncology licensing deals
Antibody-drug conjugates dominated licensing activity in 2024.
Perennial Holdings, Guangzhou Metro ink deal for landmark hospital project
The project involves a $138.8m (RMB1b) investment.
Prudential, Foshan Fosun Chancheng to enhance medical services coverage
Eligible customers will have easy access to the ‘Medical Expenses Direct Billing Service’.
China’s mechanical heart valves market to reach $50m in 2033
The country accounts for about 50% of the market share in the Asia Pacific.
China issues plan to boost health-related spending
The guidelines include improving the market supply of special foods.
iKang Healthcare Group sets new healthcare standards with cutting-edge diagnostics, state-of-the-art labs
The group, serving about 10 million individuals annually, was recognised in two categories at the Healthcare Asia Awards 2025.
China’s neurosurgical robotics market eyes 10% CAGR growth until 2036
The country accounted for 30% of APAC's robotic surgical systems market.
What lies ahead for China’s robotic surgical systems market?
Continued investment and increasing regulatory approvals will sustain market growth.
Most Read
1. China’s pharma growth shifts from drugs to high-tech manufacturing 2. Ramsay Health Care appoints new Group CFO 3. NUHS, Genesis MedTech launch four-year AI innovation partnership 4. Why China's pharma market is now a consumer game 5. St. Andrew’s Community Hospital opens second facility in Bedok SouthResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Event News
Record-breaking BD deals reflect Beijing's innovative assets are gaining massive international recognition.
